Tazarotene on SilverScript Choice (S5601-030)
Covered, with prior authorization required.
Tier 3 (preferred brand). Quantity limit of 60 per 30 days.
$19.42
Patient pays / month, after deductible
$102.23
Patient pays / month, before the $615.00 deductible
$58.27
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
TAZAROTENE 1 mg/g Cream at a preferred retail pharmacy, from the plan's negotiated price of $102.23 for a month. Other covered strengths are listed below.
Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| TAZAROTENE .5 mg/g Cream | 4 | $202.18 | PA · 60 per 30 days |
| TAZAROTENE .5 mg/g Gel | 3 | $122.38 | PA · 100 per 30 days |
| TAZAROTENE 1 mg/g Cream | 3 | $19.42 | PA · 60 per 30 days |
| TAZAROTENE 1 mg/g Gel | 3 | $101.72 | PA · 100 per 30 days |
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-030